5 completed. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
Follow pramlintide: new trials by email Literature Review of pramlintide trials Research Report on pramlintide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes Pramlintide - Type 1 Diabetes | Phase 3 | Completed | Baylor College of Medicine | 20 | 2003-10-01 | 2016-07-14 |
| Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus pramlintide acetate - Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | Phase 3 | Completed | AstraZeneca | 400 | 2003-04-01 | 2015-05-21 |
| Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus pramlintide acetate - Diabetes Mellitus, Type 1 | Phase 3 | Completed | AstraZeneca | 190 | 2002-11-01 | 2015-09-23 |
| The Role of Amylin and Glucagon in T1DM Pramlintide and glucagon - Type 1 Diabetes | Phase 3 | Completed | Baylor College of Medicine | 30 | 2002-07-01 | 2016-07-14 |
| Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control Pramlintide acetate, Placebo - Diabetes Mellitus, Type 1 | Phase 3 | Completed | AstraZeneca | 296 | 2002-04-01 | 2015-09-23 |
Diabetes Mellitus, Type 1 (5) · Diabetes Mellitus (2) · Hyperglycemia (2) · Hypoglycemia (2) · Diabetes Mellitus, Type 2 (1)
AstraZeneca (3) · Baylor College of Medicine (2)
United States (5)
Lisa Porter, MD (2) · Rubina Heptulla, MD (2)
PMID 23748514, PMID 15793249, PMID 17109671, PMID 17425446, PMID 18715216